Florin Court Capital LLP has disclosed its latest investment holdings in a recent filing, revealing a total value of approximately $96.9 million as of September 30, 2026. This update is significant as it provides insight into the company's investment strategies and the sectors it is focusing on.

Florin Court Capital LLP is a London-based investment firm that specializes in managing assets across various sectors. The firm operates under the SEC's regulations and is categorized as an investment adviser. The recent filing, dated November 2, 2026, is a Form 13F-HR, which reports the firm's holdings in publicly traded securities.

The filing indicates that Florin Court Capital holds a diverse portfolio, with investments in numerous exchange-traded funds (ETFs). The total number of entries reported in this filing is 20, showcasing a range of investment options. Notable holdings include significant positions in ETFs such as the ARK Genomic Revolution ETF and various offerings from iShares and Amplify.

"The total value of the holdings reported is $96,951,627," the filing states.

This update may have implications for various stakeholders, including current and potential investors, as it reflects Florin Court's strategic choices in a competitive investment landscape. The diverse nature of the holdings suggests a focus on sectors that are currently trending, particularly in technology and healthcare.

As for what comes next, the filing does not specify any forthcoming actions or additional disclosures. Investors and analysts will be keen to monitor future filings for further insights into Florin Court Capital's investment strategies and performance.